NEW YORK, March 20, 2017 /PRNewswire/ -- In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global generics industry. Over the years, the global generic drugs industry has grown strongly owing partly to the fact that the period for patent protection has gotten shorter with major blockbuster drugs losing their patent protection.
Furthermore, governments around the world have put in place many policies that are encouraging the growth of generic usage and regulations have also established pricing systems to promote the development of the generic drugs sector.
Aruvian Research analyzes the global generics industry in its research report Analyzing the Global Generics Industry 2017. This in-depth analysis of the global generics industry includes an industry definition, historical development of the industry, industry statistics, value and volume analysis, industry segmentation by geography, amongst others. We analyze the issue of patent expiries by therapeutic areas in details, looking at what the impact is on the generic drugs market. We also look at the industry structure, market entry as well as research & development in the industry. A Porter's Five Forces Strategy analysis of the global generics industry is also included in the report. Data analyzed in this in-depth research report is for the years 2012 to 2021.
The impact of regulatory framework on the generics industry in Europe, Japan and the United States is analyzed in the report, along with the trends and challenges in the global generics industry. We also look at the popularity of small molecule generic drugs as well as the growing focus on biosimilars. Challenge of life cycle management strategies are also looked at. Global generics industry strategies are analyzed as well.
An analysis of major markets is carried out through industry overview, industry value & volume analysis, industry segmentation by geography and an industry forecast. Key markets analyzed include Brazil, Canada, China, France, Germany, India, Italy, Japan, the Netherlands, South Africa, South Korea, Spain, the UK and the United States.
An important aspect of the global generics market is the pricing and reimbursement of generic drugs in major markets. We analyze the pricing and reimbursement in the key markets of Australia, Austria, China, Czech Republic, France, Germany, Hungary, India, Italy, Japan, Norway, Poland, Romania, Spain, Sweden, the UK and the United States.
An industry forecast of the global generics industry is included till 2021 through a value and volume forecast.
Major players in the industry are analyzed through a corporate profile, analysis of business segments, major products and services, therapeutic snapshot, financial analysis and a SWOT analysis as well. Major players analyzed in this report include Allergan, Daiichi Sankyo, Lupin, Mylan Inc, Sanofi, STADA Arzneimittel AG, TEVA Pharmaceutical Industries, Apotex, and many others.
Read the full report: http://www.reportlinker.com/p02116651-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: email@example.com
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/analyzing-the-global-generics-industry-2017-300426414.html